Sign In
Buy BAX
$27.78
+0.230 (+0.83%)
At Close: Aug 10, 2026
Baxter to Host Annual Meeting of Stockholders in Virtual Format
04:30pm, Wednesday, 25'th Mar 2026
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host its Annual Meeting of Stockholders (the 2026 Annual Meeting) in a virtual format on Tuesday,
Pet Partners and the Baxter Foundation Expand Therapy Animal Programs to Support 100,000 Patients and Healthcare Workers in Two-Year Pilot
09:00am, Wednesday, 25'th Mar 2026
Largest Single Investment from a Corporate Foundation Aims to Strengthen Healthcare Resilience by Advancing Therapy Animal Visits in U.S. Healthcare Settings BELLEVUE, Wash. and DEERFIELD, Ill.
EU regulator warns of shortage in Baxter's cancer treatment until early 2027
09:48am, Tuesday, 24'th Mar 2026
The European Union's medicines regulator said on Tuesday it expects Baxter International's cancer drugs containing ifosfamide will remain in shortage in the bloc well into the first quarter of n
Baxter Announces CFO Transition
08:45am, Monday, 16'th Mar 2026
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the departure of executive vice president and chief financial officer (CFO) Joel Grade.
Baxter International Inc. (BAX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
03:42pm, Wednesday, 11'th Mar 2026
Baxter International Inc. (BAX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Sticking With Baxter At The Lows
10:01am, Friday, 06'th Mar 2026
Baxter International faces deep investor skepticism after disappointing guidance and management's decision to delay its Investor Day. Recent leadership changes and a flattened organizational structure
Baxter International Inc. (BAX) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript
05:08pm, Thursday, 26'th Feb 2026
Baxter International Inc. (BAX) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript
Artisan Value Income Fund Q4 2025 Portfolio Activity
06:46am, Tuesday, 17'th Feb 2026
Our largest new purchase was Houston-headquartered Prosperity BancShares, the fifth-largest bank in Texas. Another notable purchase was Union Pacific, the largest freight railroad in the US. Besides o
Baxter International Inc. (NYSE:BAX) Receives Average Recommendation of “Reduce” from Brokerages
01:41am, Tuesday, 17'th Feb 2026
Baxter International Inc. (NYSE: BAX - Get Free Report) has been assigned a consensus rating of "Reduce" from the fourteen research firms that are currently covering the company, MarketBeat.com report
Pale Fire Capital Bets Big on Healthcare With a 2.07 Million Share Baxter International (BAX) Investment
12:48pm, Monday, 16'th Feb 2026
Acquired 2,074,016 shares of Baxter International Inc; estimated trade value $39.63 million based on quarterly average prices Quarter-end position value rose by $39.63 million, reflecting both new sha
Baxter International: Debt, Margin Pressure, Dreadful FY26 Guidance (Downgrade)
04:25pm, Thursday, 12'th Feb 2026
Baxter International faces a fundamental downturn after weak Q4 results and a dismal FY 2026 guide, prompting a hold rating downgrade. BAX trades at a very cheap valuation, but persistent margin compr
Baxter International Inc (BAX) Q4 2025 Earnings Call Highlights: Strong Sales Growth Amidst Margin Pressures
04:08pm, Thursday, 12'th Feb 2026
Revenue: Fourth quarter 2025 global sales from continuing operations totaled $3 billion, an increase of 8% on a reported basis and 3% on an operational basis.A
Why Baxter International Stock Was Tumbling Today
02:10pm, Thursday, 12'th Feb 2026
Its final quarter of 2025 was mixed, with a notable whiff on earnings. On the plus side, it notched a convincing beat on revenue.
Baxter International Inc. (BAX) Q4 2025 Earnings Call Transcript
01:14pm, Thursday, 12'th Feb 2026
Baxter International Inc. (BAX) Q4 2025 Earnings Call Transcript
Baxter Shares Tank As 2026 Profit Guidance Falls Below Expectations
01:10pm, Thursday, 12'th Feb 2026
Baxter reported a fourth-quarter adjusted EPS of 44 cents, below the management guidance of 52-57 cents and the Wall Street estimate of 54 cents. The decrease was driven primarily by an unfavorable p
